🇺🇸 FDA
Patent

US 6517839

Methods for inducing interleukin-12 and a type1/Th1 T-cell response

expired A61KA61K2039/55516A61K2039/57

Quick answer

US patent 6517839 (Methods for inducing interleukin-12 and a type1/Th1 T-cell response) held by The Regents of the University of California expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/55516, A61K2039/57, A61K39/39